Interestingly, in estrogen receptor (ER)-positive breast tumors, the expression level of 15-LOX-2 was reduced in the corresponding cells while the 15-LOX-1 expression level remained unchanged compared to the ER-negative tumors. This evidence concerns the gene ESR1 and breast neoplasm.